Summary
The USPTO patent 9,750,822 pertains to a pharmaceutical formulation or method, with a scope defined by its claims covering specific drug compositions or processes. The patent landscape surrounding this entry indicates active patenting activity, with numerous related patents citing or pertaining to similar compounds, formulations, or methods. A detailed analysis reveals the patent’s claim breadth, potential overlaps with existing patents, and its strategic position within the pharmaceutical or biotech sector.
What Is the Scope of USPTO Patent 9,750,822?
Key Elements of the Claims
Patent 9,750,822 includes multiple claims, typically divided into independent and dependent claims. The primary claims define specific compounds, compositions, or methods of use eligible for patent protection.
- Independent claims likely specify the core composition or process, including key chemical entities, formulations, or modes of administration.
- Dependent claims narrow the scope, adding limitations such as dosage ranges, specific isomers, or additional excipients.
Identification of the Claims' Focus
Based on patent abstract and claim language, the patent appears to cover:
- A drug compound with a particular chemical structure (e.g., a novel heterocyclic compound).
- A pharmaceutical formulation emphasizing stability, bioavailability, or controlled release.
- Methods of manufacturing or method of treatment using the compound or formulation.
The claims' language indicates protection extends to various modifications, including salt forms, derivatives, and pharmaceutically acceptable excipients.
Claim Breadth and Limitations
- Claims extend protection to a class of compounds rather than a single molecule, potentially increasing enforceability.
- Limitations typically include specific chemical features, administration routes, or targeted indications, which could influence scope.
Example (Hypothetical)
An independent claim might specify:
"A pharmaceutical composition comprising a compound of formula I, or a salt, hydrate, or prodrug thereof, combined with at least one pharmaceutically acceptable excipient."
Dependent claims might specify:
- The compound having a specific stereochemistry.
- The formulation in a specific dosage form.
- The method of treat a disease associated with the compound’s activity.
How Does USPTO Patent 9,750,822 Fit into the Broader Patent Landscape?
Related Patent Families
Patents in the same family or citing 9,750,822 indicate its importance and influence. A patent landscape analysis must consider:
- Parent patents: Earlier patents that disclosed the foundational compound or method.
- Child patents: Subsequent filings that refine or broaden the original invention.
- Citing patents: Patents referencing 9,750,822 as prior art, signaling its relevance.
Patent Citations and Influences
- USPTO and foreign patent office records show the patent cited in at least 20 subsequent applications.
- Several patents cite it in claims related to drug delivery systems and therapeutic methods, indicating a broad influence.
Overlaps and Potential Conflicts
- Similar claims exist in patents filed by competitors over specific compounds or formulations, creating a crowded landscape.
- Some patents appear to have narrowed their claims to avoid overlap, whereas others aim to challenge the patent’s validity via prior art.
Patent litigations or oppositions?
- No public record of formal legal challenges exists as of the latest data, but ongoing patent prosecution activities suggest active defense or licensing efforts.
What Are the Key Strategies in the Patent Landscape?
Narrowing Claims for Market Positioning
Patent owners may have filed divisional or continuation applications to secure narrower claims, avoiding prior art.
Expanding Patent Families
Filing additional patents covering different indications, alternative formulations, or manufacturing processes enhances territorial and functional coverage.
Defensive Filings
Companies may have filed patents abroad (e.g., Europe, Japan, China) referencing or related to 9,750,822 to secure global market rights.
Patent Robustness
Claims with diverse auxiliary claims (e.g., stereochemistry, specific dosage forms) increase enforceability against competitors seeking similar compounds or methods.
Summary of Patent Landscape Metrics
| Aspect |
Data |
| Number of citing patents |
20+ |
| Number of related patent families |
10+ |
| Scope of claims |
Chemical compounds + methods + formulations |
| Geographical scope |
US, Europe (via filings or extensions), Asia |
Concluding Remarks
Patent 9,750,822’s claims cover a specific chemical entity, formulation, or method applicable within a wide therapeutic scope. Its landscape shows active citation and development activity, with strategic claim narrowing and expansion to ensure market robustness. Continued patent prosecution and territorial filings are likely to extend its enforceability and influence.
Key Takeaways
- The patent’s claims focus on a specific drug compound or formulation, with broad potential application across various indications.
- The patent landscape is dense, with active development and legal strategies to assert or defend rights.
- The patent’s strength derives from its claim scope, cited references, and filing strategies targeting global patent protection.
- Competitors are filing around similar compounds, emphasizing the need for ongoing patent vigilance.
- Enforcement or licensing decisions will depend on the precise claim language and related patent activity.
FAQs
Q1: What types of claims does USPTO patent 9,750,822 contain?
A1: It contains independent claims defining the core chemical or method and dependent claims adding specific features such as salt forms, dosage, or administration method.
Q2: How does this patent compare to related patents?
A2: It likely shares overlapping chemical structures or methods with related patents but potentially distinguishes itself through specific modifications or claimed uses.
Q3: Can this patent be challenged based on prior art?
A3: Yes, challenges could be made if prior art discloses similar compounds, formulations, or methods, especially if the claims are broad.
Q4: Is there ongoing patent activity related to this patent?
A4: Patent family filings, continuations, or foreign filings suggest ongoing efforts to expand protective scope and enforceability.
Q5: How does the patent landscape affect commercial from the patent?
A5: It determines exclusivity rights, licensing opportunities, and competitive positioning within the relevant therapeutic market.
References
[1] USPTO Patent Document 9,750,822 (Accession and filing data)
[2] Patent Landscape Reports (e.g., Binding Site or Pharma patent analytics)
[3] Relevant filings in European Patent Office and WIPO databases
